Haemonetics Corp HAE reported upbeat earnings for the first quarter on Thursday.The company posted quarterly earnings of $1.10 per share which beat the analyst consensus estimate of$1.02 per share. The company reported quarterly sales of $321.394 million which beat the analyst consensus estimate of$305.115 million.Haemonetics affirmed FY2026 adjusted EPS guidance of $4.70 to$5.00.Haemonetics shares closed at $55.63 on Thursday.These analysts made changes to their price targets on Haemonetics following ea ...